Principal, McDermott+ Consulting 
Partner, McDermott, Will & Emery LLP

Paul is a Medicare law and policy authority who is board-certified in internal medicine and who helps clients navigate federal legislative and regulatory processes related to Medicare coverage, coding, reimbursement and compliance as well as regulatory and promotional compliance matters with the Food and Drug Administration.  Paul represents several medical professional societies as well as some of the country’s most innovative developers of pharmaceuticals, biologics, medical devices, and diagnostics before Congress, Health and Human Services, Centers for Medicare and Medicaid, Food & Drug Administration, and other federal agencies.

Representative experience includes:

  • Washington representative of the Coalition for 21st Century Medicine, a collaborative effort among developers of and stakeholders interested in advanced laboratory diagnostics.
  • Washington representative and outside regulatory and reimbursement counsel to a life-sciences company that develops and provides novel personalized medicine tests.
  • Policy and reimbursement consultant to a global specialty pharmaceutical manufacturer.
  • Reimbursement consultant to a global device, diagnostics, and nutritionals manufacturer.
  • Reimbursement consultant to a global manufacturer of diagnostic products.
  • Lead Washington representative the Diabetes Access to Care Coalition, a lobbying collaboration among three major global manufacturers of diabetes testing equipment and supplies.
  • Reimbursement consultant to a global biopharmaceutical company.
  • Reimbursement consultant to a leading manufacturer of diagnostic imaging pharmaceuticals.
Follow us on: